Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Creating a graft-friendly environment for stem cells in diseased brains
Robert Y.L. Tsai
Robert Y.L. Tsai
Published December 11, 2017
Citation Information: J Clin Invest. 2018;128(1):116-119. https://doi.org/10.1172/JCI98490.
View: Text | PDF
Commentary

Creating a graft-friendly environment for stem cells in diseased brains

  • Text
  • PDF
Abstract

Most of the adult CNS lacks regenerative activity in terms of both neuron birth and neurite outgrowth. While this regeneration-unfriendly environment of the adult CNS may preserve the existing neuronal circuitry that takes years to develop in higher organisms, it also poses a major obstacle for CNS repair later in life. In this issue of the JCI, Song et al. report on their development of a strategy that uses region-specific and molecularly engineered astrocytes to turn an unfavorable brain environment into a favorable one for engrafted neural stem/progenitor cells (NSC/NPCs). In a rat model of Parkinson’s disease (PD), cografting NPCs with midbrain-derived astrocytes engineered to overexpress the transcription factors Nurr1 and Foxa2 promotes maturation and survival of the graft, resulting in therapeutic improvement. The results of this study raise the prospect of using modified astrocytes to improve the survival, maturation, and integration of engrafted NSC/NPCs as a restorative treatment for PD.

Authors

Robert Y.L. Tsai

×

Figure 1

Host environment influences outcome of NSC/NPC transplantation in a rat model of PD.

Options: View larger image (or click on image) Download as PowerPoint
Host environment influences outcome of NSC/NPC transplantation in a rat ...
NSC/NPCs transplanted along with neurotrophic astrocytes create a friendly environment that allows their differentiation and maturation into mDA neurons. Neurotrophic astrocytes release several classes of molecules that promote mDA neuron differentiation and support long-term survival of these neurons. These include antiinflammatory cytokines (anti-iCKs), such as INF-α, INF-β, IL-1R, CCL17, and CCL22; anti-ROS molecules, including SOD3 and GPX; neurotrophic factors, such as GDNF, SHH, BDNF, NTF3, and Wnts; and neurotrophic ECM proteins, including FN1, COL6A2, ITGβ4, ITGαM, THBS1, and GPC. The presence of stress introduced by the transplantation procedure can cause neurotrophic astrocytes to become immunogenic, creating a hostile environment for transplanted NSC/NPCs. Immunogenic astrocytes hinder the maturation and survival of mDA progenitors through the production of proinflammatory cytokines (iCKs), such as IL-1β, TNF-α, iNOS, IL-6, and CXCL11, and myelin-associated proteins (MAP), including MBP, MOG, and MAG. Induced expression of Nurr1 and Foxa2 tips astrocytes toward a neutrophic phenotype, thereby promoting the maturation and survival of donor cell–derived mDA neurons. TH, tyrosine hydroxylase; nECM, neurotrophic ECM.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts